Unaudited Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Series A Preferred Stock	Preferred Stock Series A Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance, preferred stock, outstanding (in shares) at Dec. 31, 2023			0
Beginning balance at Dec. 31, 2023	$ 337,663		$ 0	$ 45	$ 652,880	$ (345)	$ (314,917)
Beginning balance, common stock, outstanding (in shares) at Dec. 31, 2023				45,167,225
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	20,231				20,231
Stock option exercises (in shares)				58,750
Stock option exercises	137				137
Stock issued – on vested RSUs (in shares)				1,001,965
Stock issued – on vested RSAs	1			$ 1
Common stock shares issued	(65)				(65)
Foreign currency translation	91					91
Unrealized gain on available-for-sale securities	46					46
Net income (loss)	(32,643)						(32,643)
Ending balance, preferred stock, outstanding (in shares) at Sep. 30, 2024			0
Ending balance at Sep. 30, 2024	325,461		$ 0	$ 46	673,183	(208)	(347,560)
Ending balance, common stock, outstanding (in shares) at Sep. 30, 2024				46,227,940
Beginning balance, preferred stock, outstanding (in shares) at Jun. 30, 2024			0
Beginning balance at Jun. 30, 2024	321,442		$ 0	$ 46	667,808	(555)	(345,857)
Beginning balance, common stock, outstanding (in shares) at Jun. 30, 2024				46,104,888
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,329				5,329
Stock option exercises (in shares)				22,500
Stock option exercises	46				46
Stock issued – on vested RSUs (in shares)				100,552
Stock issued – on vested RSAs	0
Foreign currency translation	282					282
Unrealized gain on available-for-sale securities	65					65
Net income (loss)	(1,703)						(1,703)
Ending balance, preferred stock, outstanding (in shares) at Sep. 30, 2024			0
Ending balance at Sep. 30, 2024	325,461		$ 0	$ 46	673,183	(208)	(347,560)
Ending balance, common stock, outstanding (in shares) at Sep. 30, 2024				46,227,940
Beginning balance, preferred stock, outstanding (in shares) at Dec. 31, 2024		0	0
Beginning balance at Dec. 31, 2024	$ 348,909		$ 0	$ 47	683,939	24	(335,101)
Beginning balance, common stock, outstanding (in shares) at Dec. 31, 2024	46,906,765			46,906,765
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	$ 15,916				15,916
Stock option exercises (in shares)	10,000			10,000
Stock option exercises	$ 18				18
Stock issued – on vested RSUs (in shares)				835,626
Stock issued – on vested RSAs	0			$ 1	(1)
Asset acquisition (in shares)				213,360
Common stock shares issued for PanTHERA Transaction	4,455				4,455
Unrealized gain on available-for-sale securities	106					106
Net income (loss)	(15,665)						(15,665)
Ending balance, preferred stock, outstanding (in shares) at Sep. 30, 2025		0	0
Ending balance at Sep. 30, 2025	$ 353,739		$ 0	$ 48	704,327	130	(350,766)
Ending balance, common stock, outstanding (in shares) at Sep. 30, 2025	47,965,751			47,965,751
Beginning balance, preferred stock, outstanding (in shares) at Jun. 30, 2025			0
Beginning balance at Jun. 30, 2025	$ 347,155		$ 0	$ 48	698,423	71	(351,387)
Beginning balance, common stock, outstanding (in shares) at Jun. 30, 2025				47,845,838
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,904				5,904
Stock issued – on vested RSUs (in shares)				119,913
Stock issued – on vested RSAs	0
Unrealized gain on available-for-sale securities	59					59
Net income (loss)	621						621
Ending balance, preferred stock, outstanding (in shares) at Sep. 30, 2025		0	0
Ending balance at Sep. 30, 2025	$ 353,739		$ 0	$ 48	$ 704,327	$ 130	$ (350,766)
Ending balance, common stock, outstanding (in shares) at Sep. 30, 2025	47,965,751			47,965,751